| 发明名称 | GM-CSF for use in the prevention of spontaneous abortion and embryo implantation failure | ||
| 摘要 | The invention relates to GM-CSF for use in a method for the prevention of spontaneous abortion in a subject suffering from recurrent miscarriage, comprising administering to said subject an effective amount of GM-CSF as sole active substance, wherein said method also prevents or reduces the likelihood of embryo implantation failure in the subject undergoing an assisted reproduction procedure. | ||
| 申请公布号 | US9522172(B2) | 申请公布日期 | 2016.12.20 |
| 申请号 | US201314648020 | 申请日期 | 2013.12.03 |
| 申请人 | Scarpellini Fabio;Sbracia Marco | 发明人 | Scarpellini Fabio;Sbracia Marco |
| 分类号 | A61K38/19 | 主分类号 | A61K38/19 |
| 代理机构 | Silvia Salvadori, P.C. | 代理人 | Silvia Salvadori, P.C. ;Salvadori Silvia |
| 主权项 | 1. A method of reducing the likelihood of spontaneous abortion in a subject suffering from recurrent miscarriage, or alternatively, a method of reducing the likelihood of implantation failure in a subject undergoing an assisted reproduction procedure, consisting of administering to said subject an effective amount of granulocyte macrophage-colony stimulating factor (GM-CSF), wherein the GM-CSF is administered every day at a dose of from 0.1 mcg/Kg to 100 mcg/Kg. | ||
| 地址 | Rome IT | ||